Arg-274 and Leu-277 of the gamma-aminobutyric acid type A receptor alpha(2) subunit define agonist efficacy and potency

Alanine-scanning mutagenesis and the whole cell voltage clamp technique wer e used to investigate the function of the extracellular loop between the se cond and third transmembrane domains (TM2-TM3) of the gamma-aminobutyric ac id type A receptor (GABA(A)-R). A conserved arginine residue in the TM2-TM3 loop of the GABA(A)-R alpha(2) subunit was mutated to alanine, and the mut ant alpha(2)(R274A) was co-expressed with wild-type beta(1) and gamma(2S) s ubunits in human embryonic kidney (HEIK) 293 cells. The GABA EC50 was incre ased by about 27-fold in the mutant receptor relative to receptors containi ng a wildtype alpha(2) subunit. Similarly, the GABA EC50 at alpha(2) (L277A )-beta(1 gamma)Y(2S) and alpha(2) (K279A)beta(1)gamma(2S) GABA(A)-R combina tions was increased by 51- and 4-fold, respectively. The alpha(2)(R274A) or a,(L277A) mutations also reduced the maximal response of piperidine-4-sulf onic acid relative to GABA by converting piperidine 4-sulfonic acid into a weak partial agonist at the GABA(A)-R. Based on these results, we propose t hat alpha(2)(Arg-274) and alpha(2)(Leu-277) are crucial to the efficient tr ansduction of agonist binding into channel gating at the GABA(A)-R.